Transition phase during hyperventilation therapy for persistent pulmonary hypertension of the neonate

Related Experiment Video

Updated: Aug 10, 2026

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

R Sosulski, W W Fox

    Critical Care Medicine
    |September 1, 1985
    PubMed

    Insights

    Clinicians should identify a transition phase in persistent pulmonary hypertension of the newborn (PPHN) treatment. Early recognition prevents lung disease by indicating when hyperventilation is no longer needed.

    Area of Science:

    • Neonatal Medicine
    • Pediatric Respiratory Medicine
    • Critical Care

    Background:

    • Persistent pulmonary hypertension of the newborn (PPHN) often requires mechanical ventilation and hyperventilation.
    • Prolonged hyperventilation can lead to iatrogenic lung injury in infants.
    • Identifying therapeutic transition points is crucial for optimizing PPHN management.

    Purpose of the Study:

    • To describe a transition phase in PPHN therapy where hyperventilation is no longer indicated.
    • To analyze the relationship between PaO2 and PaCO2 during different phases of PPHN treatment.
    • To correlate changes in gas exchange with the need for mechanical ventilation adjustments.

    Main Methods:

    • Retrospective analysis of ten infants with PPHN requiring hyperventilation.
    • Monitoring of arterial blood gases (PaO2, PaCO2) and alveolar-arterial oxygen gradient.
    • Assessment of PaO2 lability in relation to PaCO2 changes over time.

    Main Results:

    • Infants exhibited significant PaO2 lability inversely related to PaCO2 pre-transition.
    • A transition phase was observed, characterized by decreased PaO2 lability and reduced need for hyperventilation.
    • The ratio of PaO2 change to PaCO2 change significantly decreased post-transition (1.9 +/- 1.2) compared to pre-transition (22.4 +/- 5.2).
    • Alveolar-arterial oxygen gradient was higher and more labile pre-transition.

    Conclusions:

    • A distinct transition phase exists in PPHN treatment, signaling a decreased reliance on hyperventilation.
    • Recognizing this phase allows for ventilator setting adjustments, reducing the risk of ventilator-induced lung injury.
    • This finding supports individualized PPHN management based on evolving gas exchange patterns.

    More Related Videos

    Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures05:45

    Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

    Published on: November 2, 2015

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

    Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

    Published on: October 31, 2025

    Related Concept Videos

    Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

    Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

    Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
    Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
    Pulmonary Cycle: Exhalation01:17

    Pulmonary Cycle: Exhalation

    In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
    Hyperpnea and Hyperventilation01:25

    Hyperpnea and Hyperventilation

    Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
    Acute Respiratory Failure-II01:21

    Acute Respiratory Failure-II

    Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
    The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
    Acute Respiratory Failure-V01:29

    Acute Respiratory Failure-V

    The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
    Ensure that patients are monitored continuously for their response to therapy, including changes in...
    Mechanical Ventilation III: Noninvasive Ventilation01:23

    Mechanical Ventilation III: Noninvasive Ventilation

    Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
    Noninvasive Positive-Pressure Ventilation (NIPPV)